Anti-Keratin10 [LH2]
Invented by Prof Irene Leigh from Queen Mary University of London
Invented at Queen Mary University of London
- Datasheet
- References (6)
- Inventor Info
Info
Catalogue Number | 151115 |
Applications | FACS IHC IF IP WB |
Antigen/Gene or Protein Targets | Keratin 10 |
Synonyms |
BCIE, BIE, EHK, Keratin Type I Cytoskeletal 10, KRT10 Human Entrez Gene ID 3858 Human SwissProt P13645 Human Unigene 99936 Human Gene Symbol KRT10 Human Chromosome Location 17q21.2 |
Reactivity | Human and Mouse |
Relevance | LH2 recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). Keratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I keratin (keratins 9 to 23) and one type II keratin (keratins 1 to 8). Keratins demonstrate tissue and differentiation specific expression profiles. Keratin 10 is differentiation specific keratin that is one of the predominant keratins in suprabasal keratinocytes in stratified epthelia. Keratin 10 is a suprabasal marker of differentiation in stratified squamous epithelia and is present on all suprabasal keratinocytes. Mutations in keratin 10 cause epidermolytic hyperkeratosis. LH2 does not react with any tumour tissue regardless of histological classification. |
Host | Mouse |
Immunogen | extract of skin from psoriasis patient |
Positive Control | Extract of skin from psoriasis patient |
Subclass | IgG1 kappa |
Molecular Weight (kDa) | 56.5kDa |
Myeloma Used | Sp2/0-Ag14 |
Recommended Growing Conditions | DMEM + 5% FCS |
Strain | Balb/c |
Notes |
LH2 is monospecific and has high affinity. Cellular Localization: Cytoplasmic Suggested Dilutions: Flow Cytometry (0.5-1ug/million cells); Immunofluorescence (0.5-1ug/ml); Immunohistology (Formalin-fixed) (0.1-0.2ug/ml for 30 min at RT) (Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes) |
Research Area | Cell Signaling & Signal Transduction |
References: 6 entries
Lehman et al. 2015. Am J Pathol. 185(1):240-51. PMID: 25529795.
Barrott et al. 2011. Proc Natl Acad Sci U S A. 108(31):12752-7. PMID: 21768372.
Porter et al. 2000. Lab Invest. 80(11):1701-10. PMID: 11092530.
Reichelt et al. 1997. J Cell Sci. 110 ( Pt 18):2175-86. PMID: 9378767.
Markey et al. 1991. J Invest Dermatol. 97(5):763-70. PMID: 1717607.
Broekaert et al. 1990. Arch Dermatol Res. 282(6):383-91. PMID: 1701984.
Add a reference
References: 6 entries
Lehman et al. 2015. Am J Pathol. 185(1):240-51. PMID: 25529795.
Barrott et al. 2011. Proc Natl Acad Sci U S A. 108(31):12752-7. PMID: 21768372.
Porter et al. 2000. Lab Invest. 80(11):1701-10. PMID: 11092530.
Reichelt et al. 1997. J Cell Sci. 110 ( Pt 18):2175-86. PMID: 9378767.
Markey et al. 1991. J Invest Dermatol. 97(5):763-70. PMID: 1717607.
Broekaert et al. 1990. Arch Dermatol Res. 282(6):383-91. PMID: 1701984.
Add a reference